DeepMed Research

NATIONAL INSTITUTE ON DRUG ABUSE AND ADDICTION

🇵🇰Pakistan

Country: 🇵🇰Pakistan

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Preventing Substance Use and Risky Behavior Among Rural African American Youth

Not Applicable

Completed

Conditions: Risky Sexual Behavior

Interventions: Behavioral: FUEL
Behavioral: Strong African American Families-Teen Program

First Posted Date: 2007-09-26

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 502

Registration Number: NCT00535704

Locations: 🇺🇸
Center for Family Research, Athens, Georgia, United States

Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence

Phase 2

Completed

Conditions: Methamphetamine Dependence

Interventions: Drug: Placebo
Drug: Modafinil

First Posted Date: 2007-08-24

Last Posted Date: 2017-04-07

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 210

Registration Number: NCT00520286

Locations: 🇺🇸
Powell Chemical Dependency Center, Des Moines, Iowa, United States
🇺🇸
Matrix Institute on Addictions, Tarzana, California, United States
🇺🇸
University of Colorado Health Sciences Center, Denver, Colorado, United States

and more 5 locations

Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1

Phase 1

Conditions: Methamphetamine Dependence

First Posted Date: 2007-08-22

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 12

Registration Number: NCT00519259

Locations: 🇺🇸
Langley Porter Psychiatric Institute, San Francisco, California, United States

Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome

Phase 2

Completed

Conditions: Neonatal Abstinence Syndrome

Interventions: Drug: Clonidine HCL

First Posted Date: 2007-08-01

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 80

Registration Number: NCT00510016

Locations: 🇺🇸
Johns Hopkins Medical Institutions, Baltimore, Maryland, United States

The Discriminative Effects of Tramadol in Humans

Phase 1

Completed

Conditions: Stimulant Abuse
Stimulant Addiction
Opioid Abuse
Opioid Addiction

Interventions: Drug: tramadol
Drug: Methylphenidate
Drug: placebo
Drug: Hydromorphone

First Posted Date: 2007-07-11

Last Posted Date: 2017-10-17

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 20

Registration Number: NCT00499746

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States

Ph1 Marinol Interaction Study - Part 2 - 1

Phase 1

Completed

Conditions: Marijuana Dependence

Interventions: Drug: Placebo
Drug: Dronabinol

First Posted Date: 2007-06-22

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 12

Registration Number: NCT00490269

Locations: 🇺🇸
Uniformed Services University of Health Science, Bethesda, Maryland, United States

Reduction of Smoking in Cardiac Disease Patients

Phase 2

Completed

Conditions: Cardiovascular Disease
Tobacco Use Disorder

Interventions: Drug: Nicotine replacement
Behavioral: Motivational counseling

First Posted Date: 2007-05-07

Last Posted Date: 2017-01-10

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 152

Registration Number: NCT00469885

Locations: 🇺🇸
Univeristy of Minnesota, Minneapolis, Minnesota, United States
🇺🇸
Univerisity of Minnesota, Minneapolis, Minnesota, United States

Student Athlete Testing Using Random Notification

Not Applicable

Completed

Conditions: Drug Abuse
Substance Abuse
Alcohol Abuse

First Posted Date: 2007-03-26

Last Posted Date: 2017-01-11

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 14000

Registration Number: NCT00451854

Locations: 🇺🇸
Oregon Health & Science University, Divsion of Health Promotion & Sports Medicine, Portland, Oregon, United States

Metabolic Effects of Cocaine

Not Applicable

Completed

Conditions: Cocaine Dependence

First Posted Date: 2007-03-23

Last Posted Date: 2017-01-18

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 15

Registration Number: NCT00451230

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Positive Choice: Prevention for Positive Health

Not Applicable

Completed

Conditions: HIV Infections
Sexual Risk Behavior
Substance Use Risks

First Posted Date: 2007-03-15

Last Posted Date: 2017-01-12

Lead Sponsor: National Institute on Drug Abuse (NIDA)

Target Recruit Count: 497

Registration Number: NCT00447707

Locations: 🇺🇸
AIDS Project East Bay (APEB), Oakland, California, United States
🇺🇸
Adult Immunology Clinic, Highland Hospital, Oakland, California, United States
🇺🇸
Kaiser Permanente Medical Center, San Francisco, California, United States

and more 2 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy